ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Impact of PK/PD, Disease Models and Personalized Medicine to Influence FDA Decisions
dc.contributor.author | Powell, Robert | |
dc.date.accessioned | 2006-11-19T21:25:35Z | |
dc.date.available | 2006-11-19T21:25:35Z | |
dc.date.issued | 2006-10-26 | |
dc.identifier.uri | http://hdl.handle.net/1808/1173 | |
dc.format.extent | 2607082 bytes | |
dc.format.mimetype | application/pdf | |
dc.language | en | |
dc.relation.ispartofseries | SC | |
dc.relation.ispartofseries | 07 | |
dc.title | Impact of PK/PD, Disease Models and Personalized Medicine to Influence FDA Decisions | |
dc.type | Presentation | |
kusw.oastatus | na | |
kusw.oapolicy | This item does not meet KU Open Access policy criteria. | |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Short course 7: From Bench-Top to Clinic: How Pre-Clinical Studies can Guide Clinical Testing of Promising Drug Molecules [1]
Faculty organizer: Sandy Allerheiligen Ph.D.; Eli Lilly and Company